Filing Details
- Accession Number:
- 0001209191-18-030361
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-15 20:43:14
- Reporting Period:
- 2018-05-14
- Accepted Time:
- 2018-05-15 20:43:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652130 | Intellia Therapeutics Inc. | NTLA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1563584 | M. John Leonard | C/O Intellia Therapeutics, Inc. 40 Erie Street; Suite 130 Cambridge MA 02139 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-14 | 8,400 | $24.00 | 0 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 467,352 | Direct | |
| Common Stock | 58,415 | Indirect | By Trust |
Footnotes
- The shares were sold pursuant to a Rule 10b5-1 trading plan. All shares were sold at $24.00.
- Shares sold by the John Leonard Defined Benefit Pension Plan and Trust.
- Includes 513 and 431 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2017 and December 31, 2017, respectively.
- Shares held by the John M. Leonard 2015 Irrevocable Trust.
Billionaire Hedge Funds
